SCHEMBL7981630

SCHEMBL7981630

COc1cc2c(cc1OC)-c1cc(OC)c(OC)cc1C2

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.75
CYP3A4 P08684 2/20 0.75
KDM4E B2RXH2 3/20 0.48
MAOA P21397 3/20 0.48
ALDH1A1 P00352 2/20 0.48
ACHE P22303 2/20 0.48
GAA P10253 1/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CHEK1 O14757 2/20 0.45
DRD1 P21728 1/20 0.44
DRD4 P21917 1/20 0.44
DRD5 P21918 1/20 0.44
PDGFRB P09619 1/20 0.42
MAOB P27338 2/20 0.42
CHRNA7 P36544 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31369146 0.86 CYP3A4 (0.62) MAPTCYP3A4MAOAACHECA1
SCHEMBL4571013 0.86 CYP3A4 (1.00) MAPTCYP3A4KDM4EMAOAALDH1A1
SCHEMBL29394312 0.86 CYP3A4 (1.00) MAPTCYP3A4KDM4EMAOAALDH1A1
SCHEMBL2138785 0.86 CYP3A4 (1.00) MAPTCYP3A4KDM4EMAOAALDH1A1
SCHEMBL22953335 0.86 CYP3A4 (1.00) MAPTCYP3A4KDM4EMAOAALDH1A1
SCHEMBL7984438 0.85 MAPT (0.56) MAPTCYP3A4KDM4EALDH1A1ACHE
SCHEMBL28642174 0.85 CYP3A4 (0.56) MAPTCYP3A4KDM4EMAOAALDH1A1
SCHEMBL25646743 0.84 CYP3A4 (0.54) MAPTCYP3A4KDM4EALDH1A1ACHE
SCHEMBL16156009 0.81 CYP3A4 (0.56) MAPTCYP3A4KDM4EMAOAALDH1A1
SCHEMBL29460958 0.80 CYP3A4 (0.78) MAPTCYP3A4KDM4EMAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211226-B1 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension ALCON LABORATORIES, INC. 2001-04-03 US disclosed
US-6194439-B1 ANTICANCER AGENT PFIZER INC. 2001-02-27 US disclosed
EP-0586608-A1 TRICYCLIC POLYHYDROXYLIC TYROSINE KINASE INHIBITORS PFIZER INC. (US) 1994-03-16 EP disclosed
WO-1992021660-A1 TRICYCLIC POLYHYDROXYLIC TYROSINE KINASE INHIBITORS PFIZER, INC. (US) 1992-12-10 WO disclosed
EP-0004291-B1 REACTIVE MEDIUM FOR ELECTROCHROMIC DISPLAY DEVICES AND ELECTROCHROMIC DISPLAY INCLUDING SUCH REACTIVE MEDIUM International Business Machines Corporation (US) 1981-03-11 EP disclosed
EP-0004291-A2 Reactive medium for electrochromic display devices and electrochromic display including such reactive medium International Business Machines Corporation (US) 1979-10-03 EP disclosed
US-4139276-A Electrochromic display devices comprising substituted fluorene compounds INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1979-02-13 US disclosed